Aisling Capital Management LP

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Verona Pharma plc
VRNA
$17.95M11.011.12M0%+$06.15
Elevation Oncology, Inc.
ELEV
$14.54M5.192.83M0%+$04.98
BridgeBio Pharma, Inc.
BBIO
$187.63M3.246.07M0%+$064.26
Spruce Biosciences, Inc.
SPRB
$947,532.002.931.21M0%+$00.33
Reneo Pharmaceuticals, Inc.
RPHM
$1.47M2.65886,0750%+$00.5
Monte Rosa Therapeutics, Inc.
GLUE
$10.38M2.421.47M0%+$03.56
AVROBIO, Inc.
AVRO
$1.29M2.251.01M0%+$00.44
Biomea Fusion, Inc.
BMEA
$11.94M2.22798,7570%+$04.09
COMPASS Pathways plc
CMPS
$8.02M1.41964,5000%+$02.75
Syndax Pharmaceuticals, Inc.
SNDX
$24.39M1.211.02M0%+$08.36
Poseida Therapeutics, Inc.
PSTX
$3.33M1.081.04M0%+$01.14
Nuvation Bio Inc.
NUVB
$9.25M1.032.54M0%+$03.17
Viracta Therapeutics, Inc.
VIRX
$294,342.000.74288,5710%+$00.1
Aclaris Therapeutics, Inc.
ACRS
$538,724.000.61434,4550%+$00.19